| Bioactivity | Arginase inhibitor 7 (compound A17) is an arginase (ARG1) inhibitor, with an IC50 of 0.16 μM. Arginase inhibitor 7 has high oral bioavailability[1]. |
| Target | IC50: 0.16 ± 0.03 μM (hARG1) |
| Name | Arginase inhibitor 7 |
| CAS | 2377392-07-7 |
| Formula | C14H29BN6O5 |
| Molar Mass | 372.23 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Gzik A, et al. Novel orally bioavailable piperidine derivatives as extracellular arginase inhibitors developed by a ring expansion. Eur J Med Chem. 2023 Dec 10;264:116033. |
Arginase inhibitor 7
CAS: 2377392-07-7 F: C14H29BN6O5 W: 372.23
Arginase inhibitor 7 (compound A17) is an arginase (ARG1) inhibitor, with an IC50 of 0.16 μM. Arginase inhibitor 7 has
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.